Chu-Xia Deng (Chuxia Deng)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 41

Top Topics

Epithelial Mesenchymal Transition

Signaling Pathway

Top Venues

Nature communications

Science advances

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Tesen Zhang, Bingzhe Wang, Quansheng Cheng, Qingcheng Wang, Qingqing Zhou, Lingyun Li, Songnan Qu, Handong Sun, Chu-Xia Deng, Zikang Tang
Polaron engineering promotes NIR-II absorption of carbon quantum dots for bioimaging and cancer therapy. Science advances 10 (27) (2024)
Yangyang Feng, Ming Zhao, Lijian Wang, Ling Li, Josh Haipeng Lei, Jingbo Zhou, Jinghong Chen, Yumeng Wu, Kai Miao, Chu-Xia Deng
The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations. Cell death & disease 15 (1) (2024)
Jiao Zhai, Yingying Liu, Weiqing Ji, Xinru Huang, Ping Wang, Yunyi Li, Haoran Li, Ada Hang-Heng Wong, Xiong Zhou, Ping Chen, Lianhong Wang, Ning Yang, Chi Chen, Haitian Chen, Pui-In Mak, Chu-Xia Deng, Rui Martins, Mengsu Yang, Tsung-Yi Ho, Shuhong Yi, Hailong Yao, Yanwei Jia
Drug screening on digital microfluidics for cancer precision medicine. Nature communications 15 (1) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Chu-Xia Deng
Revealing the secret behind Epstein-Barr virus-specific tumor immune contexture. Cancer communications (London, England) 44 (4) (2024)
Chu-Xia Deng
Revealing the secret behind Epstein-Barr virus-specific tumor immune contexture. Cancer communications (London, England) 44 (4) (2024)
Jiao Zhai, Yingying Liu, Weiqing Ji, Xinru Huang, Ping Wang, Yunyi Li, Haoran Li, Ada Hang-Heng Wong, Xiong Zhou, Ping Chen, Lianhong Wang, Ning Yang, Chi Chen, Haitian Chen, Pui-In Mak, Chu-Xia Deng, Rui Martins, Mengsu Yang, Tsung-Yi Ho, Shuhong Yi, Hailong Yao, Yanwei Jia
Drug screening on digital microfluidics for cancer precision medicine. Nature communications 15 (1) (2024)
Yangyang Feng, Ming Zhao, Lijian Wang, Ling Li, Josh Haipeng Lei, Jingbo Zhou, Jinghong Chen, Yumeng Wu, Kai Miao, Chu-Xia Deng
The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations. Cell death & disease 15 (1) (2024)
Chu-Xia Deng
Revealing the secret behind Epstein-Barr virus-specific tumor immune contexture. Cancer communications (London, England) 44 (4) (2024)
Chu-Xia Deng
Revealing the secret behind Epstein-Barr virus-specific tumor immune contexture. Cancer communications (London, England) 44 (4) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Chu-Xia Deng
Revealing the secret behind Epstein-Barr virus-specific tumor immune contexture. Cancer communications (London, England) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Yangyang Feng, Ming Zhao, Lijian Wang, Ling Li, Josh Haipeng Lei, Jingbo Zhou, Jinghong Chen, Yumeng Wu, Kai Miao, Chu-Xia Deng
The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations. Cell death & disease 15 (1) (2024)
Tesen Zhang, Bingzhe Wang, Quansheng Cheng, Qingcheng Wang, Qingqing Zhou, Lingyun Li, Songnan Qu, Handong Sun, Chu-Xia Deng, Zikang Tang
Polaron engineering promotes NIR-II absorption of carbon quantum dots for bioimaging and cancer therapy. Science advances 10 (27) (2024)
Jiao Zhai, Yingying Liu, Weiqing Ji, Xinru Huang, Ping Wang, Yunyi Li, Haoran Li, Ada Hang-Heng Wong, Xiong Zhou, Ping Chen, Lianhong Wang, Ning Yang, Chi Chen, Haitian Chen, Pui-In Mak, Chu-Xia Deng, Rui Martins, Mengsu Yang, Tsung-Yi Ho, Shuhong Yi, Hailong Yao, Yanwei Jia
Drug screening on digital microfluidics for cancer precision medicine. Nature communications 15 (1) (2024)
Yangyang Feng, Ming Zhao, Lijian Wang, Ling Li, Josh Haipeng Lei, Jingbo Zhou, Jinghong Chen, Yumeng Wu, Kai Miao, Chu-Xia Deng
The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations. Cell death & disease 15 (1) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports 25 (3) (2024)
Yangyang Feng, Ming Zhao, Lijian Wang, Ling Li, Josh Haipeng Lei, Jingbo Zhou, Jinghong Chen, Yumeng Wu, Kai Miao, Chu-Xia Deng
The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations. Cell death & disease 15 (1) (2024)
Licen Li, Jianming Zeng, Xin Zhang, Yangyang Feng, Josh Haipeng Lei, Xiaoling Xu, Chu-Xia Deng, Chu-Xia Deng
Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12. EMBO reports (2024)
Si Chen, Fangyuan Shao, Jianming Zeng, Sen Guo, Lijian Wang, Heng Sun, Josh Haipeng Lei, Xueying Lyu, Shuai Gao, Qiang Chen, Kai Miao, Xiaoling Xu, Chu-Xia Deng
Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Science advances 9 (3) (2023)
Xiaodong Shu, Jianjie Li, Un In Chan, Sek Man Su, Changxiang Shi, Xin Zhang, Tingting An, Jun Xu, Lihua Mo, Jianlin Liu, Yuqing Wang, Xiaoling Li, Chen Huang, Josh Haipeng Lei, Chunfei Wang, Hao Tian, Heng Sun, Joong Sup Shim, Xuanjun Zhang, Yulun Dai, Zhicheng Yao, Xiaying Kuang, Ying Lin, Chu-Xia Deng, Xiaoling Xu
BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment that Promotes Metastasis and Immunotherapy Resistance. Cancer research (2023)
Fabrice G Petit, Christine Kervarrec, Aurélie Allais-Bonnet, Bertrand Evrard, Frédéric Chalmel, Chu-Xia Deng, Soazik P Jamin
Uterine defects and estradiol-dependent development of oviductal diverticula in mice lacking the SMAD4 C-terminal Mad homology 2 domain. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (8) (2023)
Si Chen, Fangyuan Shao, Jianming Zeng, Sen Guo, Lijian Wang, Heng Sun, Josh Haipeng Lei, Xueying Lyu, Shuai Gao, Qiang Chen, Kai Miao, Xiaoling Xu, Chu-Xia Deng
Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Science advances 9 (3) (2023)
Si Chen, Fangyuan Shao, Jianming Zeng, Sen Guo, Lijian Wang, Heng Sun, Josh Haipeng Lei, Xueying Lyu, Shuai Gao, Qiang Chen, Kai Miao, Xiaoling Xu, Chu-Xia Deng
Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Science advances 9 (3) (2023)
Si Chen, Fangyuan Shao, Jianming Zeng, Sen Guo, Lijian Wang, Heng Sun, Josh Haipeng Lei, Xueying Lyu, Shuai Gao, Qiang Chen, Kai Miao, Xiaoling Xu, Chu-Xia Deng
Cullin-5 deficiency orchestrates the tumor microenvironment to promote mammary tumor development through CREB1-CCL2 signaling. Science advances 9 (3) (2023)
Dongliang Leng, Ziyi Yang, Heng Sun, Chengcheng Song, Chen Huang, Ka U Ip, Guokai Chen, Chu-Xia Deng, Xiaohua Douglas Zhang, Qi Zhao
Comprehensive analysis of tumor microenvironment reveals prognostic ceRNA network related to immune infiltration in sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Zuqiang Wang, Hangang Chen, Qiaoyan Tan, Junlan Huang, Siru Zhou, Fengtao Luo, Dali Zhang, Jing Yang, Can Li, Bo Chen, Xianding Sun, Liang Kuang, Wanling Jiang, Zhenhong Ni, Quan Wang, Shuai Chen, Xiaolan Du, Di Chen, Chu-Xia Deng, Liangjun Yin, Lin Chen, Yangli Xie
Inhibition of aberrant Hif1α activation delays intervertebral disc degeneration in adult mice. Bone research 10 (1) (2022)
Ping Chen, Xu Zhang, Renbo Ding, Linglin Yang, Xueying Lyu, Jianming Zeng, Josh Haipeng Lei, Lijian Wang, Jiong Bi, Nan Shao, Ditian Shu, Bin Wu, Jingbo Wu, Zhihui Yang, Haiyan Wang, Biqiong Wang, Kang Xiong, Yun Lu, Shaozhi Fu, Tak Kan Choi, Ng Wai Lon, Aiping Zhang, Dongyang Tang, Yingyao Quan, Ya Meng, Kai Miao, Heng Sun, Ming Zhao, Jiaolin Bao, Lei Zhang, Xiaoling Xu, Yanxia Shi, Ying Lin, Chu-Xia Deng
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (22) (2021)
Ren-Bo Ding, Ping Chen, Barani Kumar Rajendran, Xueying Lyu, Haitao Wang, Jiaolin Bao, Jianming Zeng, Wenhui Hao, Heng Sun, Ada Hang-Heng Wong, Monica Vishnu Valecha, Eun Ju Yang, Sek Man Su, Tak Kan Choi, Shuiming Liu, Kin Iong Chan, Ling-Lin Yang, Jingbo Wu, Kai Miao, Qiang Chen, Joong Sup Shim, Xiaoling Xu, Chu-Xia Deng
Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics. Nature communications 12 (1) (2021)
Josh Haipeng Lei, Mi-Hye Lee, Kai Miao, Zebin Huang, Zhicheng Yao, Aiping Zhang, Jun Xu, Ming Zhao, Zenan Huang, Xin Zhang, Si Chen, N G Jiaying, Yuzhao Feng, Fuqiang Xing, Ping Chen, Heng Sun, Qiang Chen, Tingxiu Xiang, Lin Chen, Xiaoling Xu, Chu-Xia Deng
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (21) (2021)
Jun Tang, Weiyan Peng, Yixiao Feng, Xin Le, Kang Wang, Qin Xiang, Lili Li, Yan Wang, Can Xu, Junhao Mu, Ke Xu, Ping Ji, Qian Tao, Ailong Huang, Chu-Xia Deng, Yong Lin, Ting-Xiu Xiang
Cancer cells escape p53's tumor suppression through ablation of ZDHHC1-mediated p53 palmitoylation. Oncogene 40 (35) (2021)
Kefang Liu, Shuguang Tan, Wanjun Jin, Jiawei Guan, Qingling Wang, Huan Sun, Jianxun Qi, Jinghua Yan, Yan Chai, Zhongfu Wang, Chu-Xia Deng, George Fu Gao
N-glycosylation of PD-1 promotes binding of camrelizumab. EMBO reports 21 (12) (2020)
Jianlin Liu, Ragini Adhav, Kai Miao, Sek Man Su, Lihua Mo, Un In Chan, Xin Zhang, Jun Xu, Jianjie Li, Xiaodong Shu, Jianming Zeng, Xu Zhang, Xueying Lyu, Lakhansing Pardeshi, Kaeling Tan, Heng Sun, Koon Ho Wong, Chu-Xia Deng, Xiaoling Xu
Characterization of BRCA1-deficient premalignant tissues and cancers identifies Plekha5 as a tumor metastasis suppressor. Nature communications 11 (1) (2020)
Xianding Sun, Yang Zhou, Ruobin Zhang, Zuqiang Wang, Meng Xu, Dali Zhang, Junlan Huang, Fengtao Luo, Fangfang Li, Zhenhong Ni, Siru Zhou, Hangang Chen, Shuai Chen, Liang Chen, Xiaolan Du, Bo Chen, Haiyang Huang, Peng Liu, Liangjun Yin, Juhui Qiu, Di Chen, Chu-Xia Deng, Yangli Xie, Lingfei Luo, Lin Chen
Dstyk mutation leads to congenital scoliosis-like vertebral malformations in zebrafish via dysregulated mTORC1/TFEB pathway. Nature communications 11 (1) (2020)
Kai Miao, Josh Haipeng Lei, Monica Vishnu Valecha, Aiping Zhang, Jun Xu, Lijian Wang, Xueying Lyu, Si Chen, Zhengqiang Miao, Xin Zhang, Sek Man Su, Fangyuan Shao, Barani Kumar Rajendran, Jiaolin Bao, Jianming Zeng, Heng Sun, Ping Chen, Kaeling Tan, Qiang Chen, Koon Ho Wong, Xiaoling Xu, Chu-Xia Deng
NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation. Nature communications 11 (1) (2020)
Wei Sang, Lisi Xie, Guohao Wang, Jie Li, Zhan Zhang, Bei Li, Sen Guo, Chu-Xia Deng, Yulun Dai
Oxygen-Enriched Metal-Phenolic X-Ray Nanoprocessor for Cancer Radio-Radiodynamic Therapy in Combination with Checkpoint Blockade Immunotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (4) (2020)
Fangyuan Shao, Xueying Lyu, Kai Miao, Lisi Xie, Haitao Wang, Hao Xiao, Jie Li, Chu-Xia Deng, Renbo Ding, Ping Chen, Fuqiang Xing, Xu Zhang, Guang-Hui Luo, Wenli Zhu, Gregory Cheng, Ng Wai Lon, Scott E Martin, Guanyu Wang, Guokai Chen, Yunlu Dai, Chu-Xia Deng
Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA Screening. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 7 (23) (2020)
Heng Sun, Zhengqiang Miao, Xin Zhang, Un In Chan, Sek Man Su, Sen Guo, Chris Koon Ho Wong, Xiaoling Xu, Chu-Xia Deng
Single-cell RNA-Seq reveals cell heterogeneity and hierarchy within mouse mammary epithelia. The Journal of biological chemistry 293 (22) (2018)